Analysts expect Nutrien Ltd. (TSE:NTR) to report $0.22 EPS on May, 7 after the close.They anticipate $0.35 EPS change or 61.40% from last quarter’s $0.57 EPS. T_NTR’s profit would be $141.06M giving it 67.17 P/E if the $0.22 EPS is correct. It closed at $59.11 lastly. It is down 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.
Among 25 analysts covering Express Scripts (NASDAQ:ESRX), 8 have Buy rating, 3 Sell and 14 Hold. Therefore 32% are positive. Express Scripts had 66 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Thursday, June 1 by Credit Suisse. As per Monday, October 2, the company rating was maintained by Needham. Mizuho maintained Express Scripts Holding Company (NASDAQ:ESRX) rating on Thursday, March 8. Mizuho has “Hold” rating and $96.0 target. The rating was downgraded by William Blair to “Hold” on Thursday, March 8. The firm earned “Sell” rating on Tuesday, January 30 by Bernstein. Jefferies maintained the shares of ESRX in report on Tuesday, August 29 with “Buy” rating. The company was maintained on Thursday, July 30 by RBC Capital Markets. The company was upgraded on Wednesday, December 6 by Bernstein. Wells Fargo upgraded Express Scripts Holding Company (NASDAQ:ESRX) rating on Friday, March 9. Wells Fargo has “Hold” rating and $80.0 target. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Hold” rating by Deutsche Bank on Friday, November 4. See Express Scripts Holding Company (NASDAQ:ESRX) latest ratings:
29/03/2018 Broker: William Blair Rating: Hold Maintain
12/03/2018 Broker: Bernstein Old Rating: Underperform New Rating: Market Perform Upgrade
09/03/2018 Broker: Wells Fargo Rating: Hold New Target: $80.0 Upgrade
08/03/2018 Broker: Mizuho Rating: Hold New Target: $96.0 Maintain
08/03/2018 Broker: William Blair Rating: Hold Downgrade
08/03/2018 Broker: Maxim Group Old Rating: Buy New Rating: Hold Downgrade
08/03/2018 Broker: Jefferies Old Rating: Buy New Rating: Hold Downgrade
08/03/2018 Broker: Barclays Capital Rating: Equal-Weight New Target: $84 Initiates Coverage On
28/02/2018 Broker: Deutsche Bank Rating: Buy
27/02/2018 Broker: Bank of America Rating: Sell New Target: $77.0
The stock increased 0.61% or $0.46 during the last trading session, reaching $75.65. About 478,876 shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 24, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.
Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $42.48 billion. It operates in two divisions, PBM and Other Business Operations. It has a 9.77 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.